Pear Therapeutics Closes Temasek-Led $50M Funding Round
Pear Therapeutics Inc., a Boston-based pioneer of prescription digital therapeutics aimed at fighting addiction and mental illness, on Tuesday said it scored $50 million in a Series B financing round led...To view the full article, register now.
Already a subscriber? Click here to view full article